The Mycelium Report
Your one trusted source for everything psilocybin — curated weekly from medical journals, research papers, podcasts, YouTube, and news outlets around the world. We do the searching so you don't have to, bringing the latest science, stories, and conversations directly to our community.
Never Miss What Matters
One weekly email. The best psilocybin research, podcasts, and news from trusted sources around the world — no searching required.
New Jersey’s Psilocybin Pilot: What the Law Actually Says
New Jersey has passed a bill establishing a supervised psilocybin therapy pilot program, according to a January 2026 report in Psychology Today. The legislation creates a legal framework…
Psychedelic Use Among Veterans: What a RAND Study Found
A 2026 RAND survey study estimates that approximately 4.8 million U.S. veterans have used psilocybin mushrooms, LSD, or MDMA. About half of those veterans reported uncertainty about whether…
Microdosing Psychedelics: 10 Million Americans in 2025
A probability-based, nationally representative RAND survey of 10,122 US adults estimates that roughly 10 million Americans microdosed psilocybin, MDMA, or LSD in 2025, representing about 3.7 percent of…
Psilocybin for Depression: What the Research Actually Shows
In a 24-person Johns Hopkins study, antidepressant effects from psilocybin combined with supportive psychotherapy lasted at least a year in some patients with moderate to severe major depressive…
Psilocybin for Treatment-Resistant Depression: Mechanism Review
In a commentary published on PubMed Central, researchers reviewed two clinical trials suggesting that a single 25 mg dose of psilocybin may produce rapid antidepressant effects in treatment-resistant…
Psilocybin for Fibromyalgia: Safety in a Small Pilot
In a small open-label pilot of five adults with fibromyalgia, psilocybin-assisted therapy was reported to be safe and well tolerated, with no serious adverse events. Several participants showed…
Psilocybin Microdosing and Creative Idea Quality
In a combined analysis of three double-blind, placebo-controlled trials with 171 healthy adults, researchers found that microdosing psilocybin raised the proportion of original ideas people generated without increasing…
Psychedelic Medicine Access: Five Federal Policy Paths
A memo submitted to the Congressional Psychedelics Advancing Therapies Caucus, authored by Reason Foundation analysts, lays out five legislative approaches that could reduce scheduling barriers, expand use of…
You've Come This Far. Stay Informed.
Join our free weekly newsletter and get the best psilocybin research, medical journals, podcasts, and news — hand-curated from trusted sources around the world and delivered straight to your inbox.